Differential expression of nitric oxide synthase in human stomach cancer

  • Eunjin Koh
  • , Sung Hoon Noh
  • , Young Don Lee
  • , Hoi Young Lee
  • , Jeung Whan Han
  • , Hyang Woo Lee
  • , Sungyoul Hong

Research output: Contribution to journalArticlepeer-review

Abstract

The level of expression and cellular localization of isoenzymes of nitric oxide synthase (NOS) was detected in human stomach tumor tissues. Tumor tissues showed 70% higher activity of NOS than that of normal tissues (P<0.01). Poorly differentiated adenocarcinoma tend to have higher activity (P<0.05) than well differentiated and moderately differentiated tumor tissues. Aminoguanidine (AG), 2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine (AMT), N(G)-monomethyl-L-arginine (L-NMMA), and N(ω)-nitro-L-arginine (L-NNA) inhibited NOS activity in tumor tissues by 18, 14, 11 and 13%, respectively. The TNF-α mRNA expression was correlated with the inducible NOS (iNOS) level, which was high in adenocarcinomas and low in normal tissues. Tumor tissues showed higher expression of iNOS in gland epithelial cells but the level of eNOS was significantly decreased with an exception of concentrated localization in the proliferating capillary endothelium. These results revealed that isoforms of NOS might contribute differentially to growth and progression of human stomach tumor. Copyright (C) 1999 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)173-180
Number of pages8
JournalCancer Letters
Volume146
Issue number2
DOIs
StatePublished - 15 Nov 1999

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Differential expression
  • Human stomach cancer
  • Immunolocalization
  • Neovascularization
  • Nitric oxide synthase isozyme

Fingerprint

Dive into the research topics of 'Differential expression of nitric oxide synthase in human stomach cancer'. Together they form a unique fingerprint.

Cite this